RELATED NATIONAL AND INTERNATIONAL LINKS

• Association of Medical Microbiology and Infectious Diseases Canada (AMMI)
  www.ammi.ca AMMI is the Association of Medical Microbiology and Infectious Diseases Canada, a non-profit organization committed to contributing to the health of people at risk of, or affected by, infectious diseases. Part of AMMI’s mission is to promote, facilitate and support research and education in infectious diseases and medical microbiology.
  
  
• Alliance for the Prudent Use of Antibiotics (APUA)
  www.apua.org Since 1981, APUA has been the premier organization dedicated to promoting proper antibiotic use and curbing antibiotic resistance worldwide. We promote global public health by raising public awareness through education and research projects on proper antibiotic use and antibiotic resistance.
  
  
• British Society for Antimicrobial Chemotherapy (BSAC)
  www.bsac.org.uk Founded in 1971, and with 800 members worldwide, the British Society for Antimicrobial Chemotherapy exists to facilitate the acquisition and dissemination of knowledge in the field of antimicrobial chemotherapy.
  
  
• Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID)
  www.cacmid.ca The Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID) is an organization that began from a public health microbiology background over 70 years ago, and now has representation from medical microbiologists, clinical microbiologists, infectious disease physicians, laboratory scientists, medical technologists, laboratory managers, and research technologists.
  
  
• Canadian Bacterial Surveillance Network (CBSN)
  microbiology.mountsinai.on.ca/research/cbsn/default.asp The Canadian Bacterial Surveillance Network monitors the prevalence, mechanisms and epidemiology of antibiotic resistance in Canada. CBSN is a subgroup of the Canadian Bacterial Diseases Network, which is one of 15 Networks of Centres of Excellence (a Canada-wide consortium of researchers whose work focuses on bacterial disease).
  
  
• Canadian Committee on Antibiotic Resistance (CCAR)
  www.ccar-ccra.com The Canadian Committee on Antibiotic Resistance (CCAR) has been created to co-ordinate activities and information for health care professionals, patients, the general public and others who can help to stem the rising tide of microbial resistance to antibiotic medicines.
  
  
• International Centre for Infectious Diseases (ICID)
  www.icid.com The International Centre for Infectious Diseases (ICID) is Canada’s unique organization delivering innovative solutions to the challenges of the global fight against the infectious diseases of the 21st century. ICID is a leader and convenor within Canada’s infectious diseases community, bringing together collaborators, advocating for the sector, and encouraging the development of major initiatives.
  
  
• PubMed
  www.ncbi.nlm.nih.gov/entrez/query.fcgi?DB=pubmed PubMed is a service of the U.S. National Library of Medicine that includes over 17 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.
  
  
• T.E.S.T. (Tigecycline Evaluation and Surveillance Trial)
  www.testsurveillance.com A global multi-center surveillance study designed to assess the in vitro activity of tigecycline and comparators against a range of important pathogens, from both the community and the hospital.
  
  
• Toronto Invasive Bacterial Diseases Network (TIBDN)
  microbiology.mountsinai.on.ca/tibdn/news.asp The Toronto Invasive Bacterial Diseases Network is a collaboration of all hospitals, microbiology laboratories, infection control practitioners, physicians and public health units serving the population of metropolitan Toronto and Peel Regions (population 3.7 million). Overall, 25 hospitals, 19 laboratories and 85 LTCFs participate in this surveillance program. All surveillance activities are co-ordinated with local and provincial health departments. The goal of this network is to reduce morbidity and mortality from infectious disease by using surveillance to better understand risk factors for infection, and to improve the prevention, diagnosis and treatment of infection.